Expanding options to improve outcomes following hematopoietic stem cell transplantation.

@article{Fry2010ExpandingOT,
  title={Expanding options to improve outcomes following hematopoietic stem cell transplantation.},
  author={Terry J Fry},
  journal={Pediatric blood & cancer},
  year={2010},
  volume={55 6},
  pages={
          1043-4
        }
}
Allogeneic hematopoietic stem cell transplantation (HSCT) offers a curative option for children with a number of potentially lethal malignant and non-malignant conditions. Decisions regarding the appropriateness of HSCT for a given patient involve careful consideration of the risks associated with HSCT and the likelihood of cure. This is particularly important as the procedure is being used with increasing frequency for diagnoses such as high-risk sickle cell anemia where the disease is… CONTINUE READING